GILDGilead (GILD): New potential in 4-in-1 HIV drug11/05/09
—
Filed under: Newsletters, Gilead Sciences (GILD), Stocks to Buy"Gilead Sciences (NASDAQ: GILD) develops treatments for life-threatening diseases and specializes in drugs for HIV, the virus that causes AIDS," notes Hannah Choe.
The contributing editor to Personal Finance explains, "Already the market ...
Franco Nevada (FNV): A core holding in gold11/05/09
—
Filed under: International markets, Newsletters, Canada, Commodities, Stocks to Buy"We have very few buy recommendations currently; one exception is Franco-Nevada (Toronto: FNV.CA)," says resource expert Adrian Day.
In his The Global Analyst, the advisor explains, "Franco Nevada is one of our all-tim...
AFLCLDividend growth trio: Aflac, Medtronic and Colgate-Palmolive11/04/09
—
Filed under: Newsletters, AFLAC Inc (AFL), Colgate-Palmolive (CL), Stocks to Buy"One way to build an inflation hedge into your investment cash flows is to focus on stocks that are likely to boost their dividends on a regular basis," explains dividend specialist Chuck Carlson.
In his The DRIP Investor...
AMZNAmazon (AMZN): 'The best is still ahead'11/03/09
—
Filed under: Amazon.com (AMZN), Newsletters, Stocks to BuyTwo of the newsletter industry's leading growth stock advisors remain bullish on the prospects of online retailer Amazon.com (NASDAQ: AMZN), based on growth in not only online retailing but new market areas ranging from the Kindle e-reader to ...
VALEVale S.A. (VALE): Mining for value in iron ore11/02/09
—
Filed under: International markets, China, Brazil, Newsletters, Commodities, Oil, Stocks to Buy"We're adding Brazil's Vale S.A. (NYSE: VALE), the world's leading iron ore producer, to our model growth portfolio," says growth stock expert Stephen Leeb.
In his The Complete Investor, he explains, "This ...
Data powered by FinancialContent.
All Rights Reserved.
Quotes delayed at least 20 minutes unless otherwise indicated.
None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.